2006 Cancer Registry Report
The Cancer Registry is an integral part of the Cancer Program at Shady Grove. The Registry collects, manages and analyzes data on patients with cancer and certain precancerous conditions. Data are maintained on all cancer patients diagnosed and/or treated at Shady Grove since January 1, 1995. During 2005, 737 analytic or "new" cases were accessioned into the registry.
Registry data is reported to the Maryland Cancer Registry (per state law), the National Cancer Data Base and the American Cancer Society’s National Cancer Information Center Project. In all circumstances, confidentiality of patient identifying information is strictly maintained. Only aggregated data are analyzed and published, the individual cancer patient is never identified outside of the registry system. Cancer Registry activities are covered under HIPPA privacy rules because they are considered to be healthcare operations addressing quality assessment/improvement.
The Shady Grove Cancer Registry received Commendation during our 2005 Commission on Cancer Program Survey for consistently submitting error-free data to the National Cancer Database. Only 41 percent of accredited programs nationally were able to achieve Commendation for this Standard.
Cancer data is not just about numbers. The data that is collected by the Shady Grove Adventist Hospital Registry allows us to monitor and track our compliance with national treatment care guidelines. In 2005, the Commission on Cancer launched its Cancer Program Practice Profile Report, which monitored compliance with evidence-based guidelines for treatment of Stage III colon cancer. Shady Grove well exceeded the threshold of 80% set by the Commission, in fact, over 90% of Shady Grove Stage III colon cancer patients received chemotherapy, treatment that is known to have a survival benefit. Cancer data enables us to evaluate outcomes, the ultimate goal of therapy. We can compare our survival rates with national data. Because our database has been maintained and monitored by our Cancer Committee since 1995, not only are we able to compare 5 year survival, we can begin to look at how we are doing with long term outcomes (10 years +).
Linda Love, CTR, RHIT
Cancer Registrar
Shady Grove Adventist Hospital
| Observations |
|
An analysis of the last 5 years shows:
- The most frequent incidence is in the 50-59 year age range. In 2005, this shifted for the first time into the 60-69 year age group.
- A small but steady rise in male patients from 36% (2001) to 43.5% (2005). This is attributed in part to the addition of a prostate seed program here at Shady Grove.
- The vast majority of our patients continue to be from Montgomery County, with in 2005, these residents representing 88% of patients.
|
|
Note: In 2005, inclusion of cases reportable only to State, female CIN-3 cervix has been discontinued.
|